Prognostic Factors in Adrenocortical Carcinoma
Author Information
Author(s): H.R. Haak, C.J. Cornelisse, J. Hermans, L. Cobben, G.J. Fleuren
Primary Institution: University Hospital Leiden
Hypothesis
What is the relationship between nuclear DNA content and survival in patients with adrenocortical carcinoma?
Conclusion
Nuclear DNA content is related to the survival of patients with adrenocortical carcinomas, with diploid tumors associated with shorter survival.
Supporting Evidence
- 68% of adenomas were DNA diploid, while only 11% of carcinomas were diploid.
- Patients with diploid carcinomas had shorter survival compared to those with aneuploid tumors.
- Patients with hypo/hyperdiploid carcinomas had longer disease-free survival.
Takeaway
This study looked at how the DNA in tumors can help predict how long patients with a certain type of cancer might live.
Methodology
Flow cytometry was used to analyze nuclear DNA content in tumor samples from patients with adrenocortical tumors.
Limitations
Some tissue blocks were lost for follow-up, and the quality of histograms for some tumors was poor.
Participant Demographics
{"total_patients":149,"carcinomas":96,"adenomas":53,"age_mean":41.4,"age_sd":17.0,"sex_distribution":{"women":34,"men":20}}
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website